Group B Streptococcus Vaccine
Capsular polysaccharide-CRM197 conjugate vaccine for maternal immunization against neonatal GBS disease. HTS 3002.49.0050 for other bacterial culture-based immunological products.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Specify carrier protein origin; comply with pediatric biologics rules
• Refrigerated transport with temp logs; declare sugar content
Related Products under HTS 3002.49.00.50
Malaria RTS,S Vaccine
Recombinant circumsporozoite protein-based vaccine with AS01 adjuvant for Plasmodium falciparum. HTS 3002.49.0050 as other protozoal culture-derived prophylactic.
Human Papillomavirus Recombinant Vaccine
VLP vaccine from HPV L1 protein expression for cervical cancer prevention. Classified HTS 3002.49.0050 as other viral biotechnological product.
Human Rotavirus Vaccine
A live attenuated oral vaccine containing reassortant rotaviruses for active immunization against rotavirus gastroenteritis in infants. Classified under HTS 3002.49.0050 as it is a vaccine for human use, other than those specifically enumerated elsewhere in heading 3002. It is prepared for prophylactic purposes via biotechnological processes.
Dengue Tetravalent Vaccine
A chimeric live-attenuated tetravalent vaccine protecting against all four dengue virus serotypes for endemic prevention. Falls under HTS 3002.49.0050 as an 'other' vaccine for human prophylactic use, not matching specific viral listings. Developed through biotechnological recombination.
Cholera Oral Vaccine
Inactivated oral vaccine with recombinant B-subunit and killed whole cells for cholera prevention in travelers. HTS 3002.49.0050 applies as an 'other' microbial culture-based vaccine for prophylactic human use. Not yeast-derived, fitting chapter exclusions.
Shigella Conjugate Vaccine
Polysaccharide-protein conjugate vaccine targeting Shigella flexneri for diarrheal disease prophylaxis. Classified in HTS 3002.49.0050 as other immunological product from microbial cultures, modified biotechnologically for therapeutic use.